Diadema Partners Lp Portfolio Stock Holdings
Diadema Partners Lp disclosed 86 stock positions valued at approximately $242.2 million in its latest SEC 13F filing. The largest holdings include VIKING THERAPEUTICS INC, UNITED THERAPEUTICS CORP DEL, and JOHNSON & JOHNSON. The filing reflects positions held as of March 31, 2026 and was filed on May 15, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 86
- Portfolio Value
- $242.2M
Holdings by Sector
Diadema Partners Lp Portfolio Holdings in Q1 2026
64 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| VIKING THERAPEUTICS INC | VKTX | Healthcare | 7.06% | 525,181 | +188,332 | +55.91% | $17,089,390 |
| UNITED THERAPEUTICS CORP DEL | UTHR | Healthcare | 6.69% | 27,303 | +17,303 | +173.03% | $16,190,133 |
| JOHNSON & JOHNSON | JNJ | Healthcare | 5.43% | 53,771 | -12,673 | -19.07% | $13,143,783 |
| COGENT BIOSCIENCES INC | COGT | Healthcare | 5.13% | 322,764 | +190,912 | +144.79% | $12,423,186 |
| TERNS PHARMACEUTICALS INC | TERN | Healthcare | 3.96% | 181,752 | -164,128 | -47.45% | $9,581,965 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | Healthcare | 3.46% | 148,229 | +1,868 | +1.28% | $8,373,456 |
| ABIVAX SA | ABVX | Healthcare | 3.39% | 75,944 | +300 | +0.40% | $8,217,262 |
| REVOLUTION MEDICINES INC | RVMD | Healthcare | 3.25% | 80,872 | +43,852 | +118.45% | $7,864,802 |
| KODIAK SCIENCES INC | KOD | Healthcare | 3.04% | 192,962 | +192,962 | +100.00% | $7,355,711 |
| INCYTE CORP | INCY | Healthcare | 3.03% | 78,029 | +78,029 | +100.00% | $7,344,089 |
| TG THERAPEUTICS INC | TGTX | Healthcare | 2.84% | 206,928 | +83,645 | +67.85% | $6,874,148 |
| BRIDGEBIO PHARMA INC | BBIO | Healthcare | 2.62% | 85,311 | +15,311 | +21.87% | $6,335,195 |
| IMMUNOCORE HLDGS PLC | IMCR | Healthcare | 2.41% | 193,189 | +122,889 | +174.81% | $5,824,648 |
| ELI LILLY & CO | LLY | Healthcare | 2.28% | 6,000 | +4,000 | +200.00% | $5,518,620 |
| ABBVIE INC | ABBV | Healthcare | 2.16% | 24,058 | +24,058 | +100.00% | $5,232,374 |
| ARCUS BIOSCIENCES INC | RCUS | Healthcare | 2.12% | 238,142 | +238,142 | +100.00% | $5,143,867 |
| CORBUS PHARMACEUTICALS HLDGS | CRBP | Healthcare | 1.71% | 439,957 | +439,957 | +100.00% | $4,131,196 |
| CORVUS PHARMACEUTICALS INC | CRVS | Healthcare | 1.48% | 244,811 | +244,811 | +100.00% | $3,581,585 |
| ZYMEWORKS INC | ZYME | Healthcare | 1.47% | 142,132 | +142,132 | +100.00% | $3,558,985 |
| STRUCTURE THERAPEUTICS INC | GPCR | Healthcare | 1.44% | 72,234 | +72,234 | +100.00% | $3,481,679 |
| MONTE ROSA THERAPEUTICS INC | GLUE | Healthcare | 1.27% | 187,307 | +125,026 | +200.75% | $3,081,200 |
| TENAX THERAPEUTICS INC | TENX | Healthcare | 1.19% | 179,738 | -63,432 | -26.09% | $2,874,011 |
| HARMONY BIOSCIENCES HLDGS IN | HRMY | Healthcare | 1.07% | 92,864 | +85,364 | +1138.19% | $2,601,121 |
| CAPRICOR THERAPEUTICS INC | CAPR | Healthcare | 0.99% | 78,851 | -79,224 | -50.12% | $2,397,070 |
| EYEPOINT INC | EYPT | Healthcare | 0.95% | 178,545 | +178,545 | +100.00% | $2,301,445 |
| BICYCLE THERAPEUTICS PLC | BCYC | Healthcare | 0.91% | 476,424 | +476,424 | +100.00% | $2,210,607 |
| CLIMB BIO INC | ELYM | Other | 0.81% | 286,126 | +286,126 | +100.00% | $1,959,963 |
| SHATTUCK LABS INC | STTK | Healthcare | 0.78% | 293,664 | +293,664 | +100.00% | $1,888,260 |
| TARSUS PHARMACEUTICALS INC | TARS | Healthcare | 0.75% | 25,942 | +25,942 | +100.00% | $1,819,831 |
| ALKERMES PLC | G01767105 | Other | 0.73% | 50,000 | +50,000 | +100.00% | $1,768,000 |
| MACROGENICS INC | MGNX | Healthcare | 0.72% | 600,000 | +600,000 | +100.00% | $1,734,000 |
| VERTEX PHARMACEUTICALS INC | VRTX | Healthcare | 0.71% | 3,840 | -6,160 | -61.60% | $1,714,714 |
| VOYAGER THERAPEUTICS INC | VYGR | Healthcare | 0.68% | 423,642 | +423,642 | +100.00% | $1,635,258 |
| VAXCYTE INC | PCVX | Healthcare | 0.60% | 25,071 | +2,099 | +9.14% | $1,456,876 |
| RELMADA THERAPEUTICS INC | RLMD | Healthcare | 0.58% | 200,842 | -188,553 | -48.42% | $1,397,860 |
| INOVIO PHARMACEUTICALS INC | INO | Healthcare | 0.40% | 562,665 | +28,983 | +5.43% | $979,037 |
| AYTU BIOPHARMA INC | AYTU | Healthcare | 0.40% | 353,077 | +47,289 | +15.46% | $963,900 |
| EQUILLIUM INC | EQ | Healthcare | 0.36% | 433,844 | +86,451 | +24.89% | $867,688 |
| DIANTHUS THERAPEUTICS INC | DNTH | Healthcare | 0.35% | 10,000 | +10,000 | +100.00% | $839,200 |
| PHARVARIS N V | PHVS | Other | 0.34% | 29,321 | +29,321 | +100.00% | $828,318 |
| ENANTA PHARMACEUTICALS INC | ENTA | Healthcare | 0.34% | 64,952 | -186 | -0.29% | $820,344 |
| REPLIMUNE GROUP INC | REPL | Healthcare | 0.32% | 100,660 | -130,337 | -56.42% | $770,049 |
| XERIS BIOPHARMA HOLDINGS INC | XERS | Healthcare | 0.32% | 132,746 | -37,822 | -22.17% | $769,927 |
| LARIMAR THERAPEUTICS INC | LRMR | Healthcare | 0.31% | 166,637 | +166,637 | +100.00% | $749,867 |
| ANNEXON INC | ANNX | Healthcare | 0.30% | 132,916 | -217,084 | -62.02% | $736,355 |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | Healthcare | 0.30% | 35,144 | +35,144 | +100.00% | $736,267 |
| MINERALYS THERAPEUTICS INC | MLYS | Healthcare | 0.29% | 26,347 | +1,347 | +5.39% | $713,740 |
| PHATHOM PHARMACEUTICALS INC | PHAT | Healthcare | 0.25% | 54,650 | +54,650 | +100.00% | $607,162 |
| CELCUITY INC | CELC | Healthcare | 0.25% | 5,314 | +5,314 | +100.00% | $606,540 |
| NOVO-NORDISK A S | NVO | Healthcare | 0.22% | 14,577 | +14,577 | +100.00% | $520,736 |
| MANNKIND CORP | MNKD | Healthcare | 0.19% | 186,603 | -115,397 | -38.21% | $457,177 |
| CORCEPT THERAPEUTICS INC | CORT | Healthcare | 0.17% | 10,000 | -87,445 | -89.74% | $403,100 |
| LIPOCINE INC NEW | LPCN | Healthcare | 0.16% | 50,000 | -210,939 | -80.84% | $399,500 |
| FOGHORN THERAPEUTICS INC | FHTX | Healthcare | 0.16% | 79,944 | +49,314 | +161.00% | $382,132 |
| OCUGEN INC | OCGN | Healthcare | 0.15% | 200,000 | +200,000 | +100.00% | $362,000 |
| PEPGEN INC | PEPG | Healthcare | 0.11% | 150,925 | +150,925 | +100.00% | $267,137 |
| TREVI THERAPEUTICS INC | TRVI | Healthcare | 0.11% | 21,663 | -75,521 | -77.71% | $258,440 |
| PRECIGEN INC | PGEN | Healthcare | 0.09% | 55,293 | +55,293 | +100.00% | $213,984 |
| COMPASS PATHWAYS PLC | CMPS | Healthcare | 0.07% | 31,885 | +31,885 | +100.00% | $176,324 |
| TALPHERA INC | TLPH | Healthcare | 0.05% | 153,563 | +16,640 | +12.15% | $114,696 |
| ROCKET PHARMACEUTICALS INC | RCKT | Healthcare | 0.05% | 30,579 | +30,579 | +100.00% | $109,473 |
| VISTAGEN THERAPEUTICS INC | VTGN | Healthcare | 0.02% | 105,428 | +5,428 | +5.43% | $60,252 |
| CUE BIOPHARMA INC | CUE | Healthcare | 0.01% | 131,997 | +131,997 | +100.00% | $30,346 |
| ENLIVEN THERAPEUTICS INC | ELVN | Healthcare | 0.00% | 245 | +245 | +100.00% | $9,604 |
Diadema Partners Lp Options Holdings in Q1 2026
50 options positions in the latest reporting period.
Page 1 of 1
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q1 2026 | VRTX | Vertex Pharmaceuticals Incorpor | CALL | 93,100 | $41,572,874 |
| Q1 2026 | LQDA | Liquidia Corporation | CALL | 662,100 | $24,987,654 |
| Q1 2026 | UTHR | United Therapeutics Corporation | CALL | 40,200 | $23,837,796 |
| Q1 2026 | VKTX | Viking Therapeutics, Inc. | CALL | 659,200 | $21,450,368 |
| Q1 2026 | CAPR | Capricor Therapeutics, Inc. | PUT | 623,400 | $18,951,360 |
| Q1 2026 | APGE | Apogee Therapeutics, Inc. | CALL | 222,500 | $18,727,825 |
| Q1 2026 | CYTK | Cytokinetics, Incorporated | PUT | 200,000 | $13,182,000 |
| Q1 2026 | RVMD | Revolution Medicines, Inc. | PUT | 125,500 | $12,204,875 |
| Q1 2026 | MRK | Merck & Company, Inc. | PUT | 100,000 | $12,029,000 |
| Q1 2026 | UTHR | United Therapeutics Corporation | PUT | 20,000 | $11,859,600 |
| Q1 2026 | ABVX | Abivax SA | PUT | 100,000 | $11,135,000 |
| Q1 2026 | CAPR | Capricor Therapeutics, Inc. | CALL | 329,300 | $10,010,720 |
| Q1 2026 | INCY | Incyte Corporation | PUT | 105,400 | $9,920,248 |
| Q1 2026 | KOD | Kodiak Sciences Inc | PUT | 246,900 | $9,411,828 |
| Q1 2026 | G76279101 | Roivant Sciences | PUT | 335,800 | $9,301,660 |
| Q1 2026 | MRNA | Moderna, Inc. | PUT | 159,400 | $8,097,520 |
| Q1 2026 | EWTX | Edgewise Therapeutics, Inc. | CALL | 212,500 | $6,693,750 |
| Q1 2026 | CORT | Corcept Therapeutics Incorporat | CALL | 158,500 | $6,389,135 |
| Q1 2026 | GPCR | Structure Therapeutics Inc. | PUT | 127,500 | $6,145,500 |
| Q1 2026 | REPL | Replimune Group, Inc. | PUT | 459,900 | $3,518,235 |
| Q1 2026 | CYTK | Cytokinetics, Incorporated | CALL | 50,000 | $3,295,500 |
| Q1 2026 | PCVX | Vaxcyte, Inc. | CALL | 53,100 | $3,085,641 |
| Q1 2026 | NTLA | Intellia Therapeutics, Inc. | CALL | 200,000 | $2,564,000 |
| Q1 2026 | ALMS | Alumis Inc. | CALL | 100,000 | $2,203,000 |
| Q1 2026 | NVO | Novo Nordisk A/S | PUT | 55,900 | $2,054,325 |
| Q1 2026 | CELC | Celcuity Inc. | CALL | 17,700 | $2,020,278 |
| Q1 2026 | ANNX | Annexon, Inc. | CALL | 353,200 | $1,956,728 |
| Q1 2026 | LQDA | Liquidia Corporation | PUT | 50,000 | $1,887,000 |
| Q1 2026 | REPL | Replimune Group, Inc. | CALL | 205,500 | $1,572,075 |
| Q1 2026 | CRVS | Corvus Pharmaceuticals, Inc. | CALL | 106,300 | $1,555,169 |
| Q1 2026 | CTMX | CytomX Therapeutics, Inc. | CALL | 316,000 | $1,485,200 |
| Q1 2026 | AVXL | Anavex Life Sciences Corp. | CALL | 477,600 | $1,466,232 |
| Q1 2026 | EYPT | EyePoint Pharmaceuticals, Inc. | CALL | 106,300 | $1,370,207 |
| Q1 2026 | SLS | SELLAS Life Sciences Group, Inc | CALL | 300,000 | $1,269,000 |
| Q1 2026 | OLMA | Olema Pharmaceuticals, Inc. | CALL | 84,000 | $1,252,440 |
| Q1 2026 | CRMD | CorMedix Inc. | PUT | 167,500 | $1,137,325 |
| Q1 2026 | CRBP | Corbus Pharmaceuticals Holdings | CALL | 115,300 | $1,082,667 |
| Q1 2026 | IOVA | Iovance Biotherapeutics, Inc. | CALL | 300,000 | $1,053,000 |
| Q1 2026 | IBRX | ImmunityBio, Inc. | PUT | 106,300 | $815,321 |
| Q1 2026 | VIR | Vir Biotechnology, Inc. | CALL | 88,800 | $795,648 |
| Q1 2026 | ALMS | Alumis Inc. | PUT | 31,200 | $687,336 |
| Q1 2026 | VYGR | Voyager Therapeutics, Inc. | CALL | 150,000 | $579,000 |
| Q1 2026 | OCGN | Ocugen, Inc. | CALL | 300,000 | $543,000 |
| Q1 2026 | EOLS | Evolus, Inc. Common Stock | CALL | 125,200 | $514,572 |
| Q1 2026 | JANX | Janux Therapeutics, Inc. | CALL | 31,600 | $439,240 |
| Q1 2026 | INO | Inovio Pharmaceuticals, Inc. | CALL | 75,200 | $130,848 |
| Q1 2026 | IOVA | Iovance Biotherapeutics, Inc. | PUT | 2,900 | $10,179 |
| Q1 2026 | ATYR | aTyr Pharma, Inc. | PUT | 12,500 | $9,750 |
| Q1 2026 | ATYR | aTyr Pharma, Inc. | CALL | 12,200 | $9,516 |
| Q1 2026 | KOD | Kodiak Sciences Inc | CALL | 200 | $7,624 |
Notional value represents the total exposure of the options position.